Why Doesn't Ozempic Work for Everyone
- Dr. Shukhman
- May 8
- 3 min read
You followed the protocol. You took the medication. You dealt with the side effects and stayed consistent.
And the scale barely moved.
Or you felt sick enough that you had to stop before the medication had a real chance to work.
If that is your experience, there is something important you may not have been told before you started. Genetic variation plays a significant role in how well GLP-1 medications work and how severely patients experience side effects. For some patients, the medication was unlikely to perform the way they hoped regardless of how carefully they followed the plan.
This is not a personal failure. It is a biology problem. And it is one that physicians should be accounting for before the prescription is written.
Why Didn't Ozempic Work for Me?
New research from the 23andMe Research Institute identified specific genetic variants that predict both weight loss efficacy and adverse effects in patients taking GLP-1 medications including semaglutide and tirzepatide.
Two studies found that certain genetic profiles were associated with significantly less weight loss than average. Some patients were metabolically unlikely to respond to these drugs the way clinical trial data would suggest. A separate variant was associated with an 83% increased likelihood of experiencing vomiting on tirzepatide. That is one of the most common reasons patients discontinue treatment entirely.
Roughly 1 in 10 patients may fall into a category where the standard GLP-1 approach is either ineffective or poorly tolerated based on their individual biology. If you have been asking yourself why Ozempic did not work for you, you are not alone and there is a clinical answer worth understanding.
Can Genetics Affect How Ozempic Works?
The prescribing model most patients encounter looks like this. A physician reviews BMI, runs basic labs, and writes a prescription. The medication is the same regardless of the individual. The dose follows a standard schedule. If it does not work or feels terrible, the patient is left without a clear explanation.
What this research confirms is that the medication is not the only variable. The person is.
Two patients can take the same drug at the same dose with completely different outcomes. Not because one tried harder. Because their genetics respond differently to the mechanism of the drug.
A one-size-fits-all prescription does not account for this.
What Should a Doctor Check Before Prescribing Ozempic?
Before recommending any GLP-1 medication, a physician should have a complete picture of the individual patient. That means understanding metabolic markers beyond BMI and blood glucose. Fasting insulin, inflammatory patterns, body composition, and hormonal context all belong in that picture. Patients I see from Calabasas and Westlake Village often come in after trying a GLP-1 through a telehealth service with no personalized evaluation beforehand.
It also means an honest conversation about what the medication can and cannot do for this specific person, and what monitoring needs to happen once treatment begins.
The goal of that evaluation is not to find a reason to withhold the medication. It is to match the right approach to the right patient and avoid months of ineffective treatment or avoidable side effects.
If you tried a GLP-1 medication and it did not work the way you expected, the answer may not be to try harder. It may be to start with a more complete picture of your own biology.
Visit whiteolivedpc.com to learn more about how we approach weight loss at White Olive.
If you live in Calabasas, Hidden Hills, Westlake Village, Agoura Hills, Malibu, or the surrounding Woodland Hills area and want a physician who will actually walk through your results with you, that conversation starts with a free 15-minute intro call.
References
23andMe Research Institute. Genetic predictors of GLP-1 efficacy and adverse effects in patients taking semaglutide and tirzepatide. April 2026. research.23andme.com
Comments